Assessing The Cost Effectiveness Of A New, First-In-Class Triple Fixed Dose Combination Therapy For COPD Patients
Abstract
Authors
TB Gosden J Dhanjal D Arper A Madoni E Friggi
TB Gosden J Dhanjal D Arper A Madoni E Friggi
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now